Editor's Note: Related tickers: Smith & Wesson Holding Corp (NASDAQ:SWHC), Mellanox Technologies, Ltd. (NASDAQ:MLNX), Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), China Commercial Credit Inc (NASDAQ:CCCR)
Los Angeles County Sheriff’s Department Selects Smith & Wesson M&P Pistols (Ammoland) Smith & Wesson Holding Corp (NASDAQ:SWHC), a leader in firearm manufacturing and design, today announced that it has been awarded a firearms contract from the Los Angeles County Sheriff?s Department (LASD) for new service firearms from the Company?s M&P Pistol Series. As part of a five-year contract, the LASD will purchase Smith & Wesson M&P9 pistols which will replace currently issued non-Smith & Wesson Holding Corp (NASDAQ:SWHC) firearms. The Los Angeles County Sheriff?s Department fields approximately 13,000 sworn and non-sworn personnel who are issued duty handguns.
Mellanox and Micron Announce 40 GigE Flash Storage for Virtualized Data Centers (ConvergeDigest) Mellanox Technologies, Ltd. (NASDAQ:MLNX) and Micron today announced a collaborative solution that combines Mellanox’s ConnectX-3 40GbE NICs with iSCSI over RDMA (iSER) and Micron’s 1.4TB P420m PCIe SSD cards. The companies said the iSER protocol enables Micron’s flash storage to serve virtual machines on a single ESXi 5.1 host with an aggregate bandwidth of 11GB/s or 527,000 IOPS using only two interconnect cards in a 3U box. “The combined solution of Mellanox’s 40GbE NICs with iSER and Micron’s P420m PCIe SSD enables higher performance and accelerates storage applications running in virtualized environments,” said Yaron Haviv, vice president data center solutions at Mellanox Technologies, Ltd. (NASDAQ:MLNX).
Why Catalyst Pharmaceutical Partners is up 45 Percent Tuesday (CPRX) (BreakingFinanceNews) Shares of Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) are up 45 percent in early trading Tuesday after the company announced that its investigational drug, Firdapse has received “Breakthrough Therapy Designation” by the U.S. Food and Drug Administration. Firdapse is indicated for the symptomatic treatment of patients with Lambert-Eaton Myasthenic Syndrome, a neuromuscular condition. Breakthrough Therapy Designation is granted to a drug this is, “intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening disease or condition and preliminary clinical evidence indicates...
China Commercial Credit Issues Outlook for Coming Year; Projects 'Improved Revenue and Profit Growth' (BusinessReviewUSA) China Commercial Credit Inc (NASDAQ:CCCR), a microcredit company providing loans and loan guarantees to small-to-medium sized enterprises (SMEs), farmers and individuals, today issued a corporate outlook for the next 12 months. Mr. Huichun Qin, founder and CEO, cited three primary factors expected to fuel the company's growth: ...CCC's improved access to capital. As a result of raising $8.9 million in its recent IPO -- thereby becoming the first China-based microcredit company to go public in the U.S.